This comprehensive report provides an in-depth analysis of the global solid dosage pharmaceutical excipients market, projecting its growth trajectory from 2025 through 2032. It examines key market drivers, such as the rising prevalence of chronic diseases and advancements in drug delivery technologies, while segmenting the industry by type, application, and geography. Through detailed regional assessments and competitive profiling of leading manufacturers, the study offers strategic insights into market shares, emerging opportunities, and the evolving technological landscape.

Market Overview

The global Solid Dosage Pharmaceutical Excipients market is projected to experience significant growth from 2025 through 2032, maintaining a steady compound annual growth rate throughout the forecast period.

Solid dosage pharmaceutical excipients are inactive substances or ingredients used alongside active pharmaceutical ingredients (APIs) in the formulation of solid dosage forms such as tablets, capsules, powders, or granules. These excipients play a crucial role in the manufacturing process and the overall performance of the dosage form. While APIs are responsible for the therapeutic effect of a medication, excipients serve various functions to facilitate drug delivery, improve stability, enhance bioavailability, and provide desirable physical characteristics.

Market Dynamics

Growth Drivers

The solid dose pharmaceutical excipients market is witnessing steady growth driven by several key factors:

• Rising prevalence of chronic diseases
• Increasing demand for generic drugs
• Advancements in drug delivery technologies
• Growing global pharmaceutical industry

The market is expected to continue its upward trend in the coming years.

Regional Outlook

• North America: Expected to remain the largest market for solid dosage pharmaceutical excipients during the forecast period.
• Europe: Expected to be a major market following North America.
• Asia Pacific: Expected to be a significant market following Europe.

Report Scope and Methodology

LP Information, Inc. (LPI)'s newest research report, the “Solid Dosage Pharmaceutical Excipients Industry Forecast,” reviews total world Solid Dosage Pharmaceutical Excipients sales in 2025. It provides a comprehensive analysis by region and market sector of projected Solid Dosage Pharmaceutical Excipients sales for 2026 through 2032. With Solid Dosage Pharmaceutical Excipients sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid Dosage Pharmaceutical Excipients industry.

This Insight Report provides a comprehensive analysis of the global Solid Dosage Pharmaceutical Excipients landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies with a focus on Solid Dosage Pharmaceutical Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Solid Dosage Pharmaceutical Excipients market.

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook and breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory in the global Solid Dosage Pharmaceutical Excipients market. It presents a comprehensive overview, market shares, and growth opportunities by product type, application, key manufacturers, and key regions and countries.

Market Segmentation

By Type

• Cellulose and Derivatives
• Starch and Derivatives
• Others

By Application

• Binder
• Disintegrant
• Glidant
• Diluent
• Dispersing Agent
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

The following companies have been profiled based on inputs gathered from primary experts and an analysis of the company's coverage, product portfolio, and market penetration:

• Colorcon
• Evonik Industries
• DuPont
• JRS Pharma
• Lubrizol
• BASF
• Roquette
• Croda International
• ABITEC
• Shin-Etsu Chemical
• Associated British Foods
• Hunan ER-KANG
• Anhui Sunhere

Key Questions Addressed

• What is the 10-year outlook for the global Solid Dosage Pharmaceutical Excipients market?
• What factors are driving Solid Dosage Pharmaceutical Excipients market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Solid Dosage Pharmaceutical Excipients market opportunities vary by end market size?
• How does Solid Dosage Pharmaceutical Excipients break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Solid Dosage Pharmaceutical Excipients Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Solid Dosage Pharmaceutical Excipients by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Solid Dosage Pharmaceutical Excipients by Country/Region, 2021, 2025 & 2032

  • 2.2 Solid Dosage Pharmaceutical Excipients Segment by Type

    • 2.2.1 Cellulose and Derivatives

    • 2.2.2 Starch and Derivatives

    • 2.2.3 Others

    • 2.2.4 Solid Dosage Pharmaceutical Excipients Sales by Type

      • 2.2.4.1 Global Solid Dosage Pharmaceutical Excipients Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Solid Dosage Pharmaceutical Excipients Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Solid Dosage Pharmaceutical Excipients Sale Price by Type (2021-2026)

  • 2.3 Solid Dosage Pharmaceutical Excipients Segment by Application

    • 2.3.1 Binder

    • 2.3.2 Disintegrant

    • 2.3.3 Glidant

    • 2.3.4 Diluent

    • 2.3.5 Dispersing Agent

    • 2.3.6 Others

    • 2.3.7 Solid Dosage Pharmaceutical Excipients Sales by Application

      • 2.3.7.1 Global Solid Dosage Pharmaceutical Excipients Sale Market Share by Application (2021-2026)
      • 2.3.7.2 Global Solid Dosage Pharmaceutical Excipients Revenue and Market Share by Application (2021-2026)
      • 2.3.7.3 Global Solid Dosage Pharmaceutical Excipients Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Solid Dosage Pharmaceutical Excipients Breakdown Data by Company

    • 3.1.1 Global Solid Dosage Pharmaceutical Excipients Annual Sales by Company (2021-2026)

    • 3.1.2 Global Solid Dosage Pharmaceutical Excipients Sales Market Share by Company (2021-2026)

  • 3.2 Global Solid Dosage Pharmaceutical Excipients Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Solid Dosage Pharmaceutical Excipients Revenue by Company (2021-2026)

    • 3.2.2 Global Solid Dosage Pharmaceutical Excipients Revenue Market Share by Company (2021-2026)

  • 3.3 Global Solid Dosage Pharmaceutical Excipients Sale Price by Company

  • 3.4 Key Manufacturers Solid Dosage Pharmaceutical Excipients Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Solid Dosage Pharmaceutical Excipients Product Location Distribution

    • 3.4.2 Players Solid Dosage Pharmaceutical Excipients Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Solid Dosage Pharmaceutical Excipients by Geographic Region

  • 4.1 World Historic Solid Dosage Pharmaceutical Excipients Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Solid Dosage Pharmaceutical Excipients Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Solid Dosage Pharmaceutical Excipients Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Solid Dosage Pharmaceutical Excipients Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Solid Dosage Pharmaceutical Excipients Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Solid Dosage Pharmaceutical Excipients Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Solid Dosage Pharmaceutical Excipients Sales Growth

  • 4.4 APAC Solid Dosage Pharmaceutical Excipients Sales Growth

  • 4.5 Europe Solid Dosage Pharmaceutical Excipients Sales Growth

  • 4.6 Middle East & Africa Solid Dosage Pharmaceutical Excipients Sales Growth

• 5 Americas

  • 5.1 Americas Solid Dosage Pharmaceutical Excipients Sales by Country

    • 5.1.1 Americas Solid Dosage Pharmaceutical Excipients Sales by Country (2021-2026)

    • 5.1.2 Americas Solid Dosage Pharmaceutical Excipients Revenue by Country (2021-2026)

  • 5.2 Americas Solid Dosage Pharmaceutical Excipients Sales by Type (2021-2026)

  • 5.3 Americas Solid Dosage Pharmaceutical Excipients Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Solid Dosage Pharmaceutical Excipients Sales by Region

    • 6.1.1 APAC Solid Dosage Pharmaceutical Excipients Sales by Region (2021-2026)

    • 6.1.2 APAC Solid Dosage Pharmaceutical Excipients Revenue by Region (2021-2026)

  • 6.2 APAC Solid Dosage Pharmaceutical Excipients Sales by Type (2021-2026)

  • 6.3 APAC Solid Dosage Pharmaceutical Excipients Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Solid Dosage Pharmaceutical Excipients by Country

    • 7.1.1 Europe Solid Dosage Pharmaceutical Excipients Sales by Country (2021-2026)

    • 7.1.2 Europe Solid Dosage Pharmaceutical Excipients Revenue by Country (2021-2026)

  • 7.2 Europe Solid Dosage Pharmaceutical Excipients Sales by Type (2021-2026)

  • 7.3 Europe Solid Dosage Pharmaceutical Excipients Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Solid Dosage Pharmaceutical Excipients by Country

    • 8.1.1 Middle East & Africa Solid Dosage Pharmaceutical Excipients Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Solid Dosage Pharmaceutical Excipients Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Solid Dosage Pharmaceutical Excipients Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Solid Dosage Pharmaceutical Excipients Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Solid Dosage Pharmaceutical Excipients

  • 10.3 Manufacturing Process Analysis of Solid Dosage Pharmaceutical Excipients

  • 10.4 Industry Chain Structure of Solid Dosage Pharmaceutical Excipients

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Solid Dosage Pharmaceutical Excipients Distributors

  • 11.3 Solid Dosage Pharmaceutical Excipients Customer

• 12 World Forecast Review for Solid Dosage Pharmaceutical Excipients by Geographic Region

  • 12.1 Global Solid Dosage Pharmaceutical Excipients Market Size Forecast by Region

    • 12.1.1 Global Solid Dosage Pharmaceutical Excipients Forecast by Region (2027-2032)

    • 12.1.2 Global Solid Dosage Pharmaceutical Excipients Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Solid Dosage Pharmaceutical Excipients Forecast by Type (2027-2032)

  • 12.7 Global Solid Dosage Pharmaceutical Excipients Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Colorcon

    • 13.1.1 Colorcon Company Information

    • 13.1.2 Colorcon Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.1.3 Colorcon Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Colorcon Main Business Overview

    • 13.1.5 Colorcon Latest Developments

  • 13.2 Evonik Industries

    • 13.2.1 Evonik Industries Company Information

    • 13.2.2 Evonik Industries Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.2.3 Evonik Industries Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Evonik Industries Main Business Overview

    • 13.2.5 Evonik Industries Latest Developments

  • 13.3 DuPont

    • 13.3.1 DuPont Company Information

    • 13.3.2 DuPont Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.3.3 DuPont Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 DuPont Main Business Overview

    • 13.3.5 DuPont Latest Developments

  • 13.4 JRS Pharma

    • 13.4.1 JRS Pharma Company Information

    • 13.4.2 JRS Pharma Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.4.3 JRS Pharma Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 JRS Pharma Main Business Overview

    • 13.4.5 JRS Pharma Latest Developments

  • 13.5 Lubrizol

    • 13.5.1 Lubrizol Company Information

    • 13.5.2 Lubrizol Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.5.3 Lubrizol Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Lubrizol Main Business Overview

    • 13.5.5 Lubrizol Latest Developments

  • 13.6 BASF

    • 13.6.1 BASF Company Information

    • 13.6.2 BASF Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.6.3 BASF Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 BASF Main Business Overview

    • 13.6.5 BASF Latest Developments

  • 13.7 Roquette

    • 13.7.1 Roquette Company Information

    • 13.7.2 Roquette Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.7.3 Roquette Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Roquette Main Business Overview

    • 13.7.5 Roquette Latest Developments

  • 13.8 Croda International

    • 13.8.1 Croda International Company Information

    • 13.8.2 Croda International Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.8.3 Croda International Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Croda International Main Business Overview

    • 13.8.5 Croda International Latest Developments

  • 13.9 ABITEC

    • 13.9.1 ABITEC Company Information

    • 13.9.2 ABITEC Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.9.3 ABITEC Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 ABITEC Main Business Overview

    • 13.9.5 ABITEC Latest Developments

  • 13.10 Shin-Etsu Chemical

    • 13.10.1 Shin-Etsu Chemical Company Information

    • 13.10.2 Shin-Etsu Chemical Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.10.3 Shin-Etsu Chemical Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Shin-Etsu Chemical Main Business Overview

    • 13.10.5 Shin-Etsu Chemical Latest Developments

  • 13.11 Associated British Foods

    • 13.11.1 Associated British Foods Company Information

    • 13.11.2 Associated British Foods Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.11.3 Associated British Foods Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Associated British Foods Main Business Overview

    • 13.11.5 Associated British Foods Latest Developments

  • 13.12 Hunan ER-KANG

    • 13.12.1 Hunan ER-KANG Company Information

    • 13.12.2 Hunan ER-KANG Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.12.3 Hunan ER-KANG Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Hunan ER-KANG Main Business Overview

    • 13.12.5 Hunan ER-KANG Latest Developments

  • 13.13 Anhui Sunhere

    • 13.13.1 Anhui Sunhere Company Information

    • 13.13.2 Anhui Sunhere Solid Dosage Pharmaceutical Excipients Product Portfolios and Specifications

    • 13.13.3 Anhui Sunhere Solid Dosage Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Anhui Sunhere Main Business Overview

    • 13.13.5 Anhui Sunhere Latest Developments

• 14 Research Findings and Conclusion